Search research articles
Contact Us
Filters
Showing results (21-30 of 311) with videos related to
Page
of 32
Sort By:
European Urology
|
December 8, 2009
Prostate cancer, depression, and risk of suicide: should we pay more attention?
Bertrand Tombal
European Urology
|
December 4, 2008
Words of wisdom. Re: toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study
Bertrand Tombal
European Urology
|
March 24, 2009
Intermittent androgen deprivation therapy: conventional wisdom versus evidence
Bertrand Tombal
The Lancet. Oncology
|
June 30, 2014
Will new AR inhibitors reshape the prostate cancer landscape?
Bertrand Tombal
The Lancet. Oncology
|
August 8, 2015
N-of-1 trials in oncology
Laurence Collette, Bertrand Tombal
European Urology
|
May 1, 2012
Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Bertrand Tombal, Frederic Lecouvet
Current Opinion in Urology
|
May 13, 2022
Editorial: Metastatic prostate cancer: a wealth of data to put into practice
Bertrand Tombal, Himisha Beltran
The Canadian Journal of Urology
|
April 30, 2014
Practical guide to bone health in the spectrum of advanced prostate cancer
Valentina Butoescu, Bertrand Tombal
Advances in Urology
|
October 21, 2011
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Bertrand Tombal, Frederic Lecouvet
European Urology Oncology
|
May 20, 2019
Management of Prostate Cancer Patients with Clinically Positive Lymph Nodes
Silke Gillessen, Bertrand Tombal
Page
of 32
Search research articles
Search
Showing results (21-30 of 311) with videos related to
Sort By:
Page
of 32
European Urology
|
December 8, 2009
Prostate cancer, depression, and risk of suicide: should we pay more attention?
Bertrand Tombal
European Urology
|
December 4, 2008
Words of wisdom. Re: toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study
Bertrand Tombal
European Urology
|
March 24, 2009
Intermittent androgen deprivation therapy: conventional wisdom versus evidence
Bertrand Tombal
The Lancet. Oncology
|
June 30, 2014
Will new AR inhibitors reshape the prostate cancer landscape?
Bertrand Tombal
The Lancet. Oncology
|
August 8, 2015
N-of-1 trials in oncology
Laurence Collette, Bertrand Tombal
European Urology
|
May 1, 2012
Words of wisdom: Re: Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
Bertrand Tombal, Frederic Lecouvet
Current Opinion in Urology
|
May 13, 2022
Editorial: Metastatic prostate cancer: a wealth of data to put into practice
Bertrand Tombal, Himisha Beltran
The Canadian Journal of Urology
|
April 30, 2014
Practical guide to bone health in the spectrum of advanced prostate cancer
Valentina Butoescu, Bertrand Tombal
Advances in Urology
|
October 21, 2011
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?
Bertrand Tombal, Frederic Lecouvet
European Urology Oncology
|
May 20, 2019
Management of Prostate Cancer Patients with Clinically Positive Lymph Nodes
Silke Gillessen, Bertrand Tombal
Page
of 32